Fundamental dimension Equity attribute | BCBPPeer $8.63▲+0.47% Cap $149.8MP/E -7.8x QuantScore44/100 | BFINPeer $12.000.00% Cap $149.5MP/E 74.4x QuantScore34/100 | CFBKLeader $34.48▼-0.26% Cap $221.2MP/E 11.8x QuantScore65/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
73/100 |
48/100 |
84/100 |
Valuation Multiples, PEG & DCF upside | 67/100 | 50/100 | 84/100 |
Health Piotroski, Altman Z, leverage & liquidity | 41/100 | 39/100 | 48/100 |
Growth Revenue / earnings growth & margins | 7/100 | 32/100 | 40/100 |
Sentiment Analyst ratings, targets & revisions | 30/100 | 0/100 | 67/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -7.8x | 74.4x | 11.8x |
Forward P/E (next FY) | -1.1x | 17.9x | 9.7x |
EV / EBITDA (TTM) | -14.4x | -15.6x | 3.8x |
Price / Sales | 1.0x | 4.1x | 1.8x |
Price / Free Cash Flow | 4.3x | -1371.8x | 12.3x |
PEG ratio | -0.00 | -1.06 | 2.53 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 8 / 9 | 6 / 9 |
Altman Z-Score | 0.11 (Distress) | -0.31 (Distress) | 0.36 (Distress) |
Total debt / equity | 0.61 | 0.18 | 0.62 |
Quick ratio | 2.7x | 0.5x | 15.4x |
Interest coverage | -0.3x | 0.2x | 0.4x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -15.5% | +4.5% | +3.1% |
Net income growth YoY | -167.3% | -56.6% | +27.0% |
Gross margin (TTM) | 24.9% | 67.4% | 43.8% |
Operating margin (FY) | -11.0% | 6.8% | 17.1% |
FCF margin (FY) | 21.0% | 7.4% | 14.5% |
5. Trailing price performancePrice change over period |
1M return | -1.4% | 0.0% | -0.1% |
3M return | -14.9% | +5.9% | +3.1% |
6M return | -13.7% | +12.1% | +17.2% |
Year to date | +6.9% | 0.0% | +38.2% |
1Y return | +5.1% | -10.0% | +44.9% |
3Y return | -10.3% | +14.2% | +123.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $13.85 +60.5% upside | $16.82 +40.2% upside | $58.45 +69.5% upside |
Wall Street consensus target | $9.50 +10.1% · range $9.50–$9.50 | — — | $40.00 +16.0% · range $40.00–$40.00 |
Consensus stance | 0% Buy100% Hold0% Sell | 0% Buy100% Hold0% Sell | 100% Buy0% Hold0% Sell |